Healthcare -
Biotechnology - NASDAQ - US
$ 2.11
9.33 %
$ 45.7 M
Market Cap
-0.73
P/E
ALRN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ALRN - Aileron Therapeutics, Inc.
15.8 M
LAST VALUE
-46.73%
2 YEAR CAGR
44.41%
5 YEAR CAGR
0.50%
10 YEAR CAGR